Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Anatomic Stage III Breast Cancer: early-phase trial registry

1 of 1 indexed Anatomic Stage III Breast Cancer trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Anatomic Stage III Breast Cancer: 1 US clinical trial tracked, 1 recruiting.

Anatomic Stage III Breast Cancer is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Vanderbilt-Ingram Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition anatomic-stage-iii-breast-cancer

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Anatomic Stage III Breas (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Anatomic Stage III Breast Cancer

Anatomic Stage III Breast Cancer lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Anatomic Stage III Breast Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Anatomic Stage III Breast Cancer is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Anatomic Stage III Breast Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mammogram Procedure
1 trials
Neratinib Drug
1 trials
Biopsy of breast Procedure
1 trials
Endocrine Therapy Procedure
1 trials
Biospecimen Collection Procedure
1 trials

US sites by state

Facility locations filed on Anatomic Stage III Breast Cancer trials. A trial with sites in several states counts in each.

Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Anatomic Stage III Breast Cancer page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anatomic Stage III Breast Cancer condition card totals 1 registered trials; most-linked intervention Mammogram; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.